Capillary electrophoresis for the control of impurities of rDNA somatropin.
In the European Pharmacopoeia, the monographs on somatropin, somatropin bulk solution and somatropin for injection prescribe a number of tests including "related substances", "dimer and related substances of higher molecular weight" and "isoform distribution" which are intended to control the levels of impurities in the substance. The aim of this study was to verify the robustness of a new method by capillary electrophoresis and to compare its performance with that of the existing test for "isoform distribution" by isoelectric focusing. It was demonstrated that the capillary electrophoresis method was superior to the method of isoelectric focusing. The interest of the CZE method consists in the resolution of related impurities that might be process specific and/or generated by the expression system.
Charton
E
E
European Directorate for the Quality of Medicines, Council of Europe, BP 907, F-67029 Strasbourg Cedex 1, France.
Miller
J H McB
JH
Briançon
F
F
Rautmann
G
G
D018076:DNA, Complementary / Q000592:standards*; D019075:Electrophoresis, Capillary / Q000592:standards*; D005060:Europe; D019382:Human Growth Hormone / Q000592:standards*; D006801:Humans; D015203:Reproducibility of Results
D018076:DNA, Complementary; D019382:Human Growth Hormone